Is Post-Lipiodol CT Better Than IV Contrast CT Scan for Early Detection of HCC? A Single Liver Transplant Center Experience

S. Rizvi, C. Camci, Y. Yong, G. Parker, S. Shrago, K. Stokes, H. Wright, A. Sebastian, Ahmet Gurakar

Research output: Contribution to journalArticle

Abstract

Hepatocellular carcinoma is a highly vascular neoplasm usually arising from a cirrhotic liver. Delayed, noncontrast, computed tomography (CT) imaging after 7 to 14 days reveals an oil-based contrast agent to be concentrated in the tumor but not in normal hepatic parenchyma. The aim of this study was to retrospectively correlate the post Lipiodol CT scan findings with respect to tumor size in the explanted liver. We retrospectively reviewed adult patients who had undergone orthotopic liver transplantation between November 1995 and December 2004 and also had an hepatic arteriogram with Lipiodol injection as part of their pretransplant workup. We calculated sensitivity, specificity, false-negativity, false-positivity, and accuracy of the test, as well as positive and negative predictive values. Lipiodol CT exam had sensitivity of 1.0; specificity of 0.6 with a calculated positive predictive value of 0.89 and a negative predictive value of 1.0. Overall accuracy of Lipiodol CT scan test was found to be 0.91, which was superior to an intravenous contrast CT alone. In conclusion, because of the higher sensitivity and accuracy values, hepatic arterial Lipiodol injection can be considered during the pretransplantation workup of high-risk cirrhotic patients, since the current model for End-stage Liver Disease scoring system for hepatocellular carcinoma is built on the ultimate bulk of the tumor. Further multicenter, controlled, large-volume prospective studies are warranted to verify this observation.

Original languageEnglish (US)
Pages (from-to)2993-2995
Number of pages3
JournalTransplantation Proceedings
Volume38
Issue number9
DOIs
StatePublished - Nov 2006
Externally publishedYes

Fingerprint

Ethiodized Oil
Tomography
Transplants
Liver
Hepatocellular Carcinoma
Vascular Neoplasms
Sensitivity and Specificity
Neoplasms
Injections
End Stage Liver Disease
Liver Transplantation
Contrast Media
Oils
Prospective Studies

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Is Post-Lipiodol CT Better Than IV Contrast CT Scan for Early Detection of HCC? A Single Liver Transplant Center Experience. / Rizvi, S.; Camci, C.; Yong, Y.; Parker, G.; Shrago, S.; Stokes, K.; Wright, H.; Sebastian, A.; Gurakar, Ahmet.

In: Transplantation Proceedings, Vol. 38, No. 9, 11.2006, p. 2993-2995.

Research output: Contribution to journalArticle

Rizvi, S. ; Camci, C. ; Yong, Y. ; Parker, G. ; Shrago, S. ; Stokes, K. ; Wright, H. ; Sebastian, A. ; Gurakar, Ahmet. / Is Post-Lipiodol CT Better Than IV Contrast CT Scan for Early Detection of HCC? A Single Liver Transplant Center Experience. In: Transplantation Proceedings. 2006 ; Vol. 38, No. 9. pp. 2993-2995.
@article{9d2818776d5343ef9f07021a6abbd27b,
title = "Is Post-Lipiodol CT Better Than IV Contrast CT Scan for Early Detection of HCC? A Single Liver Transplant Center Experience",
abstract = "Hepatocellular carcinoma is a highly vascular neoplasm usually arising from a cirrhotic liver. Delayed, noncontrast, computed tomography (CT) imaging after 7 to 14 days reveals an oil-based contrast agent to be concentrated in the tumor but not in normal hepatic parenchyma. The aim of this study was to retrospectively correlate the post Lipiodol CT scan findings with respect to tumor size in the explanted liver. We retrospectively reviewed adult patients who had undergone orthotopic liver transplantation between November 1995 and December 2004 and also had an hepatic arteriogram with Lipiodol injection as part of their pretransplant workup. We calculated sensitivity, specificity, false-negativity, false-positivity, and accuracy of the test, as well as positive and negative predictive values. Lipiodol CT exam had sensitivity of 1.0; specificity of 0.6 with a calculated positive predictive value of 0.89 and a negative predictive value of 1.0. Overall accuracy of Lipiodol CT scan test was found to be 0.91, which was superior to an intravenous contrast CT alone. In conclusion, because of the higher sensitivity and accuracy values, hepatic arterial Lipiodol injection can be considered during the pretransplantation workup of high-risk cirrhotic patients, since the current model for End-stage Liver Disease scoring system for hepatocellular carcinoma is built on the ultimate bulk of the tumor. Further multicenter, controlled, large-volume prospective studies are warranted to verify this observation.",
author = "S. Rizvi and C. Camci and Y. Yong and G. Parker and S. Shrago and K. Stokes and H. Wright and A. Sebastian and Ahmet Gurakar",
year = "2006",
month = "11",
doi = "10.1016/j.transproceed.2006.08.125",
language = "English (US)",
volume = "38",
pages = "2993--2995",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Is Post-Lipiodol CT Better Than IV Contrast CT Scan for Early Detection of HCC? A Single Liver Transplant Center Experience

AU - Rizvi, S.

AU - Camci, C.

AU - Yong, Y.

AU - Parker, G.

AU - Shrago, S.

AU - Stokes, K.

AU - Wright, H.

AU - Sebastian, A.

AU - Gurakar, Ahmet

PY - 2006/11

Y1 - 2006/11

N2 - Hepatocellular carcinoma is a highly vascular neoplasm usually arising from a cirrhotic liver. Delayed, noncontrast, computed tomography (CT) imaging after 7 to 14 days reveals an oil-based contrast agent to be concentrated in the tumor but not in normal hepatic parenchyma. The aim of this study was to retrospectively correlate the post Lipiodol CT scan findings with respect to tumor size in the explanted liver. We retrospectively reviewed adult patients who had undergone orthotopic liver transplantation between November 1995 and December 2004 and also had an hepatic arteriogram with Lipiodol injection as part of their pretransplant workup. We calculated sensitivity, specificity, false-negativity, false-positivity, and accuracy of the test, as well as positive and negative predictive values. Lipiodol CT exam had sensitivity of 1.0; specificity of 0.6 with a calculated positive predictive value of 0.89 and a negative predictive value of 1.0. Overall accuracy of Lipiodol CT scan test was found to be 0.91, which was superior to an intravenous contrast CT alone. In conclusion, because of the higher sensitivity and accuracy values, hepatic arterial Lipiodol injection can be considered during the pretransplantation workup of high-risk cirrhotic patients, since the current model for End-stage Liver Disease scoring system for hepatocellular carcinoma is built on the ultimate bulk of the tumor. Further multicenter, controlled, large-volume prospective studies are warranted to verify this observation.

AB - Hepatocellular carcinoma is a highly vascular neoplasm usually arising from a cirrhotic liver. Delayed, noncontrast, computed tomography (CT) imaging after 7 to 14 days reveals an oil-based contrast agent to be concentrated in the tumor but not in normal hepatic parenchyma. The aim of this study was to retrospectively correlate the post Lipiodol CT scan findings with respect to tumor size in the explanted liver. We retrospectively reviewed adult patients who had undergone orthotopic liver transplantation between November 1995 and December 2004 and also had an hepatic arteriogram with Lipiodol injection as part of their pretransplant workup. We calculated sensitivity, specificity, false-negativity, false-positivity, and accuracy of the test, as well as positive and negative predictive values. Lipiodol CT exam had sensitivity of 1.0; specificity of 0.6 with a calculated positive predictive value of 0.89 and a negative predictive value of 1.0. Overall accuracy of Lipiodol CT scan test was found to be 0.91, which was superior to an intravenous contrast CT alone. In conclusion, because of the higher sensitivity and accuracy values, hepatic arterial Lipiodol injection can be considered during the pretransplantation workup of high-risk cirrhotic patients, since the current model for End-stage Liver Disease scoring system for hepatocellular carcinoma is built on the ultimate bulk of the tumor. Further multicenter, controlled, large-volume prospective studies are warranted to verify this observation.

UR - http://www.scopus.com/inward/record.url?scp=33750960465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750960465&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2006.08.125

DO - 10.1016/j.transproceed.2006.08.125

M3 - Article

C2 - 17112883

AN - SCOPUS:33750960465

VL - 38

SP - 2993

EP - 2995

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 9

ER -